<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
-------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) August 29, 2000
-----------------------------
Asthma Disease Management, Inc.
-------------------------------------------------------------------------------
(Exact Name of Registrant as specified in its charter)
Delaware 33-1534-D 22-3253496
-------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
272 South White Horse Pike, Berlin, NJ 08009
-------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code 800-448-8199
---------------------------
-------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events
On August 29, 2000, Asthma Disease Management, Inc. (the "Company") and
the Company's current Board of Directors filed a complaint in the Delaware
Chancery Court against certain of the Company's former officers, directors and
employees, alleging, among other things, that such former officers, directors
and employees engaged in unlawful issuances of stock and other breaches of
fiduciary duties. The action alleges, among other things, that the defendants
caused the Company to unlawfully issue up to 53 million unauthorized shares of
the Company's Common Stock. The action seeks declaratory relief, injunctive
relief and damages.
<PAGE>
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ASTHMA DISEASE MANAGEMENT, INC.
Dated: September 28, 2000 By: /s/ A.J. Henley
--------------------------------
Name: A.J. Henley
Title: President and
Chief Executive Officer
